Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology

Journal of Alzheimer's Disease

Volumn 21, Issue 3, 2010, Pages 795-811

  Proctor, Dustin T ^a   Coulson, Elizabeth J ^a   Dodd, Peter R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cytoskeletal scaffold; excitotoxicity; glutamate receptors; neurodegeneration; post synaptic density; signaling

Indexed keywords

APOLIPOPROTEIN E4; GLUTAMATE RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN SAP 102; SCAFFOLD PROTEIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; OCCIPITAL CORTEX; PATHOLOGY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TEMPORAL CORTEX;

EID: 77957273679     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100090     Document Type: Article

References (80)

1. Terry RD, Masliah E, Salmon DP, Butters N, Deteresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572580.
2. Tannenberg RK, Scott HL, Westphalen RI, Dodd PR (2004) The identification and characterization of excitotoxic nerveendings in Alzheimer disease. Curr Alzheimer Res 1, 1125.
3. Hynd MR, Scott HL, Dodd PR (2004) Differential expression of NmethylDaspartate receptor NR2 isoforms in Alzheimer's disease. J Neurochem 90, 913919. (Pubitemid 39099973)
4. Hynd MR, Scott HL, Dodd PR (2004) Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's disease. J Neurochem 89, 240247.
5. Dewachter I, Filipkowski RK, Priller C, Ris L,Neyton J, Croes S, Terwel D, GysemansM, Devijver H, Borghgraef P, Godaux E, Kaczmarek L, Herms J, Van Leuven F (2009) Deregulation of NMDAreceptor function and downstream signaling in APP [V717I] transgenic mice. Neurobiol Aging 30, 241256.
6. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid protein induce reversible synapse loss by modulating an NMDAtype glutamate receptordependent signaling pathway. J Neurosci 27, 28662875.
7. Cho KO, Hunt CA, Kennedy MB (1992) The rat brain postsynaptic density fraction contains a homolog of the Drosophila discslarge tumor suppressor protein. Neuron 9, 929942.
8. Sans N, Petralia RS, Wang YX, Blahos J, 2nd, Hell JW,Wenthold RJ (2000) A developmental change in NMDA receptorassociated proteins at hippocampal synapses. J Neurosci 20, 12601271. (Pubitemid 30220482)
9. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A 88, 63686371.
10. Thorns V, Hansen L,Masliah E (1998) nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp Neurol 150, 1420. (Pubitemid 28146418)
11. Leuba G, Savioz A, Vernay A, Carnal B, Kraftsik R, Tardif E, Riederer I, Riederer BM (2008) Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD95 postsynaptic protein. J Alzheimers Dis 15, 139151.
12. Leuba G, Walzer C, Vernay A, Carnal B, Kraftsik R, Piotton F, Marin P, Bouras C, Savioz A (2008) Postsynaptic density protein PSD95 expression inAlzheimer's disease and okadaic acid induced neuritic retraction. Neurobiol Dis 30, 408419.
13. Gylys KH, Fein JA, Yang F, Wiley DJ, Miller CA, Cole GM (2004) Synaptic changes in Alzheimer's disease: Increased amyloid and gliosis in surviving terminals is accompanied by decreased PSD95 fluorescence. Am J Pathol 165, 18091817.
14. Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM, Gouras GK (2005) amyloid accumulation in APP mutant neurons reduces PSD95 and GluR1 in synapses. Neurobiol Dis 20, 187198. (Pubitemid 41476246)
15. Roselli F, Tirard M, Lu J, Hutzler P, Lamberti P, Livrea P, Morabito M, Almeida OF (2005) Soluble amyloid1- 40 induces NMDAdependent degradation of postsynaptic density95 at glutamatergic synapses. J Neurosci 25, 1106111070.
16. Dracheva S, Marras SA, Elhakem SL, Kramer FR, Davis KL, Haroutunian V (2001) NmethylDaspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 158, 14001410. (Pubitemid 32847238)
17. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, PericakVance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921923.
18. Ashford JW (2004) APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci 23, 157165.
19. Qiu Z, Crutcher KA, Hyman BT, Rebeck GW (2003) ApoE isoforms affect neuronal NmethylDaspartate calcium responses and toxicity via receptormediated processes. Neuroscience 122, 291303. (Pubitemid 37410161)
20. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850852. (Pubitemid 24193454)
21. Halliday GM, Ng T, Rodriguez M, Harding A, Blumbergs P, Evans W, Fabian V, Fryer J, Gonzales M, Harper CG, Kalnins R, Masters CL, McLean C, Milder DG, Pamphlett R, Scott G, Tannenberg AEG, Kril JJ (2002) Consensus neuropathological diagnosis of common dementia syndromes: Testing and standardising the use of multiple diagnostic criteria. Acta Neuropathol 104, 7278. (Pubitemid 36075361)
22. Dodd PR, Hardy JA, Baig EB, Kidd AM, Bird ED, Watson WEJ, Johnston GAR (1986) Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain. Neurochem Pathol 4, 177198.
23. Tannenberg RK, Scott HL, Tannenberg AE, Dodd PR (2006) Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE "4. Neurochem Int 49, 631639.
24. Walton HS,Gebhardt FM, Innes DJ,Dodd PR (2007) Analysis of multiple exonskipping mRNA splice variants using SYBR Green realtime RTPCR. J Neurosci Methods 160, 294301.
25. Sambrook J, Fritsch EF, Maniatis T (1989) Extraction, purification, and analysis of messenger RNA from eukaryotic cells In Molecular Cloning: A Laboratory Manual, Nolan C, ed. Cold Spring Harbour Press, Cold Spring Harbour, pp. 6.1- 6.62.
26. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545548.
27. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folinphenol reagent. J Biol Chem 193, 265275.
28. Gebhardt FM, Scott HA, Dodd PR (2009) Housekeepers for accurate transcript expression analysis in Alzheimer's disease autopsy brain tissue. Alzheimers Dement, in press (doi: 10.1016/j.jalz.2009.1011.1002).
29. Ridge JP, Ho AMC, Innes DJ, Dodd PR (2008) The expression of NMDA receptor subunit mRNA in human chronic alcoholics. Ann N Y Acad Sci 1139, 1019.
30. Winer BJ, Brown DR, Michels KM (1991) Statistical Principles in Experimental Design, McGrawHill, Sydney, NS.W.
31. Knobloch M, Mansuy IM (2008) Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol 37, 7382.
32. Parameshwaran K, Dhanasekaran M, Suppiramaniam V (2008) Amyloid- peptides and glutamatergic synaptic dysregulation. Exp Neurol 210, 713.
33. Arendt T (2009) Synaptic degeneration in Alzheimer's disease. Acta Neuropathol 118, 167179.
34. Scott HL, Tannenberg AEG, Dodd PR (1995) Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J Neurochem 64, 21932202.
35. Van Zundert B, Yoshii A, ConstantinePaton M (2004) Receptor compartmentalization and trafficking at glutamate synapses: A developmental proposal. Trends Neurosci 27, 428437.
36. Cuthbert PC, Stanford LE, CobaMP,Ainge JA, Fink AE,Opazo P, Delgado JY, Komiyama NH, O'Dell TJ, Grant SG (2007) Synapseassociated protein 102/dlgh3 couples the NMDA receptor to specific plasticity pathways and learning strategies. J Neurosci 27, 26732682. (Pubitemid 46393587)
37. Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, Auberson YP, Wang YT (2004) Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304, 10211024. (Pubitemid 38638102)
38. Massey PV, JohnsonBE,Moult PR,AubersonYP,BrownMW, Molnar E, CollingridgeGL, Bashir ZI (2004)Differential roles of NR2A and NR2Bcontaining NMDA receptors in cortical longterm potentiation and longterm depression. J Neurosci 24, 78217828. (Pubitemid 39215685)
39. Mufson EJ, Kordower JH (1992) Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proc Natl Acad Sci U S A 89, 569573.
40. Tarpey P, Parnau J, Blow M, Woffendin H, Bignell G, Cox C, Cox J, Davies H, Edkins S, Holden S, Korny A, Mallya U, Moon J, O'Meara S, Parker A, Stephens P, Stevens C, Teague J,DonnellyA,MangelsdorfM,Mulley J, PartingtonM, Turner G, Stevenson R, Schwartz C, Young I, Easton D, Bobrow M, Futreal PA, Stratton MR, Gecz J, Wooster R, Raymond FL (2004) Mutations in the DLG3 gene cause nonsyndromic Xlinked mental retardation. Am J Hum Genet 75, 318324. (Pubitemid 38943875)
41. Qu M, Aronica E, Boer K, Fallmar D, Kumlien E, Nister M, Wester K, Ponten F, Smits A (2009) DLG3/SAP102 protein expression in malformations of cortical development: A study of human epileptic cortex by tissue microarray. Epilepsy Res 84, 3341.
42. Zanni G, Van Esch H, Bensalem A, Saillour Y, Poirier K, Castelnau L, RopersHH, deBrouwerAP, Laumonnier F, Fryns JP, Chelly J (2009) A novel mutation in the DLG3 gene encoding the synapseassociated protein 102 (SAP102) causes nonsyndromic mental retardation. Neurogenetics 11, 251255.
43. McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B,MeadorWoodruff JH (2007) Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res 1127, 108118. (Pubitemid 44854837)
44. Kristiansen LV, MeadorWoodruff JH (2005) Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression. Schizophr Res 78, 8793.
45. Beneyto M,MeadorWoodruff JH (2008) Laminaspecific abnormalities of NMDA receptorassociated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 33, 21752186. (Pubitemid 351992080)
46. Clinton SM, MeadorWoodruff JH (2004) Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 29, 13531362.
47. Groc L, Heine M, Cousins SL, Stephenson FA, Lounis B, Cognet L, Choquet D (2006) NMDA receptor surface mobility depends on NR2A2B subunits. Proc Natl Acad Sci U S A 103, 1876918774. (Pubitemid 44913485)
48. Cousins SL, Papadakis M, Rutter AR, Stephenson FA (2008) Differential interaction of NMDA receptor subtypes with the postsynaptic density95 family of membrane associated guanylate kinase proteins. J Neurochem 104, 903913. (Pubitemid 351143653)
49. Han K, Kim E (2008) Synaptic adhesion molecules and PSD95. Prog Neurobiol 84, 263283.
50. EliasGM, Elias LA,Apostolides PF,KriegsteinAR,NicollRA (2008) Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD95 underlies synapse development. Proc Natl Acad Sci U S A 105, 2095320958.
51. Zhang J, Diamond JS (2009) Subunitand pathwayspecific localization of NMDA receptors and scaffolding proteins at ganglion cell synapses in rat retina. J Neurosci 29, 42744286.
52. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Fröhner SC, Bredt DS (1996) Interaction of nitric oxide synthase with the postsynaptic density protein PSD95 and-1syntrophin mediated by PDZ domains. Cell 84, 757767.
53. Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T (1999) PSD95 promotes Fynmediated tyrosine phosphorylation of the NmethylDaspartate receptor subunit NR2A. Proc Natl Acad Sci U S A 96, 435440. (Pubitemid 29061226)
54. Iwamoto T, Yamada Y, Hori K, Watanabe Y, Sobue K, Inui M (2004) Differential modulation of NR1NR2A and NR1NR2B subtypes of NMDA receptor by PDZ domaincontaining proteins. J Neurochem 89, 100108. (Pubitemid 38420678)
55. Lin Y, Skeberdis VA, Francesconi A, Bennett MV, Zukin RS (2004) Postsynaptic density protein95 regulates NMDA channel gating and surface expression. J Neurosci 24, 1013810148. (Pubitemid 39492039)
56. ElHusseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS (2000) PSD95 involvement in maturation of excitatory synapses. Science 290, 13641368.
57. Nikonenko I, Boda B, Steen S, Knott G, Welker E, Muller D (2008) PSD95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling. J Cell Biol 183, 11151127.
58. Steiner P, Higley MJ, Xu W, Czervionke BL, Malenka RC, Sabatini BL (2008) Destabilization of the postsynaptic density by PSD95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity. Neuron 60, 788802.
59. Kim K, Yang J, Zhong XP, Kim MH, Kim YS, Lee HW, Han S, Choi J, Han K, Seo J, Prescott SM, Topham MK, Bae YC, Koretzky G, Choi SY, Kim E (2009) Synaptic removal of diacylglycerol by DGK- and PSD95 regulates dendritic spine maintenance. EMBO J 28, 11701179.
60. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from A-142 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95, 64486453.
61. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid- protein potently inhibit hippocampal longterm potentiation in vivo. Nature 416, 535539.
62. Rowan MJ, Klyubin I, Cullen WK, Anwyl R (2003) Synaptic plasticity in animal models of early Alzheimer's disease. Philos Trans R Soc Lond B Biol Sci 358, 821828. (Pubitemid 36536714)
63. Selkoe DJ (2008) Soluble oligomers of the amyloid-protein impair synaptic plasticity and behavior. Behav Brain Res 192, 106113.
64. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, LambertMP,Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL (2004) Synaptic targeting by Alzheimer'srelated amyloid- oligomers. J Neurosci 24, 1019110200.
65. Colledge M, Snyder EM, Crozier RA, Soderling JA, Jin Y, Langeberg LK, LuH, BearMF, Scott JD(2003)Ubiquitination regulates PSD95 degradation and AMPA receptor surface expression. Neuron 40, 595607. (Pubitemid 37494707)
66. Kirvell SL, Esiri M, Francis PT (2006) Downregulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease. J Neurochem 98, 939950. (Pubitemid 44051293)
67. Agarwal S, Tannenberg RK, Dodd PR (2008) Reduced expression of the inhibitory synapse scaffolding protein gephyrin in Alzheimer's disease. J Alzheimers Dis 14, 313321. (Pubitemid 352040046)
68. Kashani A, Lepicard E, Poirel O, Videau C, David JP, FalletBianco C, Simon A, Delacourte A, Giros B, Epelbaum J, Betancur C, El Mestikawy S (2008) Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline inAlzheimer disease. Neurobiol Aging 29, 16191630.
69. MukaetovaLadinska EB, GarciaSiera F, Hurt J, Gertz HJ, Xuereb JH,Hills R, Brayne C,Huppert FA, Paykel ES,McGee M, Jakes R, Honer WG, Harrington CR, Wischik CM (2000) Staging of cytoskeletal and-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol 157, 623636. (Pubitemid 30626921)
70. Gotthardt M, Trommsdorff M, Nevitt MF, Shelton J, Richardson JA, Stockinger W, Nimpf J, Herz J (2000) Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem 275, 2561625624. (Pubitemid 30658816)
71. Hardingham GE, Fukunaga Y, Bading H (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shutoff and cell death pathways. Nat Neurosci 5, 405414. (Pubitemid 34454245)
72. TrottiD,AokiM, Pasinelli P, Berger U,Danbolt NC, Brown R, Hediger MA (2001) Amyotrophic lateral sclerosislinked glutamate transporter mutant has impaired glutamate clearance capacity. J Biol Chem 276, 576582. (Pubitemid 32050354)
73. Hynd MR, Lewohl JM, Scott HL, Dodd PR (2003) Biochemical and molecular studies using human autopsy brain tissue. J Neurochem 85, 543562.
74. Hardy JA, Dodd PR (1983) Metabolic and functional studies on postmortem human brain. Neurochem Int 5, 253266. (Pubitemid 13034848)
75. Dekaban AS (1978) Changes in brain weights during the span of human life: Relation of brain weights to body heights and body weights. Ann Neurol 4, 345356.
76. Hedden T, Gabrieli JD (2004) Insights into the ageing mind: A view from cognitive neuroscience. Nat Rev Neurosci 5, 8796. (Pubitemid 38160284)
77. Lewohl JM, Wang L, Miles MF, Zhang L, Dodd PR, Harris RA (2000) Gene expression in human alcoholism: microarray analysis of frontal cortex. AlcoholClinExp Res 24, 18731882. (Pubitemid 32001860)
78. Ghaemmaghami S, HuhWK, Bower K, Howson RW, Belle A, Dephoure N,O'Shea EK,Weissman JS (2003) Global analysis of protein expression in yeast. Nature 425, 737741. (Pubitemid 37314318)
79. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, Wang YT, Salter MW, Tymianski M (2002) Treatment of ischemic brain damage by perturbing NMDA receptorPSD95 protein interactions. Science 298, 846850. (Pubitemid 35231541)
80. Bach A, Chi CN, Olsen TB, Pedersen SW, Røder MU, Pang GF, Clausen RP, Jemth P, Strømgaard K (2008) Modified peptides as potent inhibitors of the postsynaptic density95/NmethylDaspartate receptor interaction. J Med Chem 51, 64506459.